 |
| The First Word |  Top |
|
 |
|
Bananas and Biotech Consumers p417
Susan Hassler
doi:10.1038/nbt0595-417
PDF
(139K)
|
|
| Correspondence | Top |
|
|
|
Serum Situation p418
Jens-Uwe Kraeber
doi:10.1038/nbt0595-418a
PDF
(151K)
|
|
|
|
Serum Situation p418
Ted Maker
doi:10.1038/nbt0595-418b
PDF
(151K)
|
|
| Commentary | Top |
|
|
|
The Third Vaccine Revolution p420
Bernard Dixon
doi:10.1038/nbt0595-420
PDF
(113K)
|
|
| News & Commentary | Top |
|
|
|
152 U.S. biopharmaceutical firms lose $13 billon pp422 - 425
Vicki Glaser
doi:10.1038/nbt0595-422
PDF
(730K)
|
|
|
|
The U.K. biotech sector isn't down and out pp425 - 426
Mike Ward
doi:10.1038/nbt0595-425
PDF
(237K)
|
|
|
|
Acquisition as a best-case scenario pp426 - 427
Fariba Fischel Ghodsian
doi:10.1038/nbt0595-426
PDF
(236K)
|
|
|
|
Gene therapy's new business plan pp429 - 431
Robert Abbott
doi:10.1038/nbt0595-429
PDF
(650K)
|
|
|
|
Review of NIHRAC focuses on gene therapy pp431 - 432
Jeffrey L. Fox
doi:10.1038/nbt0595-431
PDF
(315K)
|
|
|
|
Mycogen magically turns around Agrigenetics p433
George Kidd
doi:10.1038/nbt0595-433
PDF
(133K)
|
|
|
|
EPA okays first pesticidal transgenic plants pp434 - 435
Russ Hoyle
doi:10.1038/nbt0595-434
PDF
(283K)
|
|
|
|
Pharmacoeconomics: Drug pricing's new guise pp435 - 436
Jeffrey L. Fox
doi:10.1038/nbt0595-435
PDF
(335K)
|
|
| Articles | Top |
|
|
|
Nanotechnology's Many Disciplines pp439 - 443
Daniel Thomas
doi:10.1038/nbt0595-439
Abstract + references | PDF
(1,277K)
|
|
|
|
Protein Crystals and Bioelectronic Arrays p441
Musa Mhlanga
doi:10.1038/nbt0595-441
References | PDF
(380K)
|
|
|
|
Nanotechnolosy Muscles In p442
Musa Mhlanga
doi:10.1038/nbt0595-442
PDF
(302K)
|
|
|
|
The Era of Intracellular Nucleic Acid Technology pp445 - 447
Ronnie A. Ray, Penelope J. Cooper
& Andrew J. Wakefield
doi:10.1038/nbt0595-445
Abstract + references | PDF
(523K)
|
|
|
|
Clinical Systems for the Production of Human Cells and Tissues pp449 - 453
R.Douglas Armstrong, Walter C. Ogier
& James Maluta
doi:10.1038/nbt0595-449
Abstract + references | PDF
(652K)
|
|
|
|
From Pots to Plots: Genetically Modified Plants on Trial pp454 - 458
Patricia Ahl Goy
& John H. Duesing
doi:10.1038/nbt0595-454
Abstract + references | PDF
(1,240K)
|
|
| Biotools | Top |
|
|
|
Intellectual Property Under GATT pp460 - 462
Elizabeth Enayati
doi:10.1038/nbt0595-460
Abstract + references | PDF
(468K)
|
|
|
|
Managing Clinical Data pp463 - 466
Suzanne K. Bishop
& Ronald D. Eng
doi:10.1038/nbt0595-463
Abstract | PDF
(512K)
|
|
| Review | Top |
|
|
|
Phytoremediation: A Novel Strategy for the Removal of Toxic Metals from the Environment Using Plants pp468 - 474
David E. Salt, Michael Blaylock, Nanda P.B.A. Kumar, Viatcheslav Dushenkov, Burt D. Ensley, Ilan Chet
& Ilya Raskin
doi:10.1038/nbt0595-468
Abstract + references | PDF
(903K)
|
|
| Research | Top |
|
|
|
Antibody VH Domains as Small Recognition Units pp475 - 479
Julian Davies
& Lutz Riechmann
doi:10.1038/nbt0595-475
Abstract + references | PDF
(661K)
|
|
|
|
Genetic Transformation of Banana and Plantain (Musa spp.) via Particle Bombardment pp481 - 485
László Sági, Bart Panis, Serge Remy, Hilde Schoofs, Kris De Smet, Rony Swennen
& Bruno P.A. Cammue
doi:10.1038/nbt0595-481
Abstract + references | PDF
(769K)
|
|
|
|
Generation of Transgenic Banana (Musa acuminata) Plants via Agrobacterium-Mediated Transformation pp486 - 492
Gregory D. May, Rownak Afza, Hugh S. Mason, Alicja Wiecko, Frantisek J. Novak
& Charles J. Arntzen
doi:10.1038/nbt0595-486
Abstract + references | PDF
(1,012K)
|
|
|
|
Aggregation of a Lyophilized Pharmaceutical Protein, Recombinant Human Albumin: Effect of Moisture and Stabilization by Excipients pp493 - 496
Henry R. Costantino, Robert Langer
& Alexander M. Klibanov
doi:10.1038/nbt0595-493
Abstract + references | PDF
(494K)
|
|
|
|
A System for Production of Commercial Quantities of Human Lactoferrin: A Broad Spectrum Natural Antibiotic pp498 - 503
Pauline P. Ward, Christopher S. Piddington, Grainne A. Cunningham, Xiaodong Zhou, Roger D. Wyatt
& Orla M. Conneely
doi:10.1038/nbt0595-498
Abstract + references | PDF
(922K)
|
|
|
|
Improved N-terminal Processing of Recombinant Proteins Synthesized in Escherichia coli pp504 - 506
Kathleen Sandman, Rowan A. Grayling
& John N. Reeve
doi:10.1038/nbt0595-504
Abstract + references | PDF
(385K)
|
|
|
|
Protease-Dependent Streptomycin Sensitivity in E. coli—A System for Protease Inhibitor Selection pp507 - 510
Robert F. Balint
& Ingrid Plooy
doi:10.1038/nbt0595-507
Abstract + references | PDF
(575K)
|
|
| Reader Service | Top |
|
|
|
| BioReactors |
|
|
|
Bioreactors p511
doi:10.1038/nbt0595-511
PDF
(122K)
|
|
 |
|
| New Products |
|
|
|
New Products p512
doi:10.1038/nbt0595-512
PDF
(130K)
|
|
| Announcements | Top |
|
|
|
Announcements p513
doi:10.1038/nbt0595-513
PDF
(109K)
|
|
| The Last Word | Top |
|
|
|
Biotechnology, Biodiversity, and Conservation p522
Angela Karp
& David S. Ingram
doi:10.1038/nbt0595-522
PDF
(125K)
|
|
|
Top |
|
|
